We had previously reported that loss of GSTA1 is a major determinant of neutropenia among breast cancer patients receiving standard dose FAC (5-fluorouracil, doxorubicin, cyclophosphamide) chemotherapy8. This evidence concerns the gene GSTA1 and neutropenia.